Durvalumab vs Escitalopram

Durvalumab vs Escitalopram: Overview

This comparison examines the pharmacological differences between Durvalumab and Escitalopram.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Escitalopram: S-enantiomer of citalopram; selective serotonin reuptake inhibitor.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Escitalopram — 27-32 hours.

Chemical Properties

Molecular Formula: Escitalopram — C20H21FN2O.

Molecular Weight: Escitalopram — 324.3920 g/mol.

Type: Durvalumab — Antibody; Escitalopram — Small molecule.